Theriva™ Biologics has announced a strategic agreement that will allow it to raise up to $4 million through the immediate exercise of warrants. This capital will be used to strengthen its working capital and facilitate its corporate operations. The company, listed on the New York Stock Exchange under the symbol TOVX, specializes in developing therapies aimed at treating cancer and associated diseases, focusing on areas that require innovative approaches.
The agreement allows institutional investors to exercise warrants enabling the purchase of up to 7,360,460 common shares at a price of $0.54 per share, thereby generating an estimated gross income of $4 million before expenses and commissions. This exercise will be available until 11:30 a.m. (ET) and also includes the possibility of increasing the gross income by an additional $400,000.
Additionally, upon the full exercise of the warrants, investors will receive new unregistered warrants that will offer them the option to acquire up to 14,720,920 common shares, again at $0.54 per share. These new warrants will be subject to shareholder approval and will have a validity period of five years.
The company has projected that the closing of this incentive transaction will occur around October 17, 2025, subject to customary closing conditions. For this transaction, A.G.P./Alliance Global Partners has acted as exclusive financial advisor.
It is important to note that the new warrants and the shares to be issued upon their exercise are not registered under the U.S. Securities Act and cannot be offered or sold without such registration unless an exemption applies. This offering is restricted to accredited investors.
Theriva™ Biologics continues to advance with a diversified approach to oncology research, developing innovative platforms, including oncolytic adenoviruses designed to target tumor cells and enhance the efficacy of adjunct treatments. The company remains committed to transforming cancer care and providing vital solutions in areas where they are needed.
Source: MiMub in Spanish
